Yield10 Bioscience Inc reports results for the quarter ended in September - Earnings Summary

Yield10 Bioscience

10/11/2021 22:42

* Yield10 Bioscience Inc  YTEN.OQ  reported a quarterly adjusted
loss of 49 cents​​ per share for the quarter ended in September.
The mean expectation of two analysts for the quarter was for a
loss of 65 cents per share.
* Revenue fell 54.9% to $92.00 thousand from a year ago; 
analysts expected $207.00 thousand. 
* Yield10 Bioscience Inc's reported EPS for the quarter was a
loss of 49 cents​.
* The mean earnings estimate of analysts had fallen by
about 21.5% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Yield10 Bioscience Inc shares had risen by 1.8% this
quarter and gained 5.5% so far this year.
* The company reported a quarterly loss of $2.4 million.
* Wall Street's median 12-month price target for Yield10
Bioscience Inc is $25.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 10 at 10:41 p.m.
 ​All figures in US dollars unless otherwise stated